共 295 条
[1]
Giliberto F(2014)Symptomatic female carriers of Duchenne muscular dystrophy (DMD): genetic and clinical characterization J Neurol Sci 336 36-41
[2]
Radic CP(2018)Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management Lancet Neurol 17 347-361
[3]
Luce L(2002)Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation Neuromuscul Disord 12 926-929
[4]
Ferreiro V(2007)Managing Duchenne muscular dystrophy - the additive effect of spinal surgery and home nocturnal ventilation in improving survival Neuromuscul Disord 17 470-475
[5]
de Brasi C(2008)Neuropsychiatric disorders in males with duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive-compulsive disorder J Child Neurol 23 477-481
[6]
Szijan I(2017)The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review Orphanet J Rare Dis 12 79-1498
[7]
Birnkrant DJ(2017)Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Lancet 390 1489-3
[8]
Bushby K(2014)Italian risk-sharing agreements on drugs: are they worthwhile? Eur J Health Econ 16 1-491
[9]
Bann CM(2014)A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy Neuromuscul Disord 24 482-268
[10]
Alman BA(2014)Prevalence of muscular dystrophies: a systematic literature review Neuroepidemiology 43 259-946